Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls.
Aarnoutse R, Hillege LE, Ziemons J, De Vos-Geelen J, de Boer M, Aerts EMER, Vriens BEPJ, van Riet Y, Vincent J, van de Wouw AJ, Le GN, Venema K, Rensen SS, Penders J, Smidt ML. Aarnoutse R, et al. Among authors: van riet y. Cancers (Basel). 2021 Dec 9;13(24):6200. doi: 10.3390/cancers13246200. Cancers (Basel). 2021. PMID: 34944820 Free PMC article.
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM, Goorts B, Klinkert M, Keymeulen KBMI, De Vries B, Strobbe LJA, Wauters CAP, van Riet YE, Degreef E, Rutgers EJT, Wesseling J, Smidt ML. van Roozendaal LM, et al. Among authors: van riet ye. Breast Cancer Res Treat. 2016 Apr;156(3):517-525. doi: 10.1007/s10549-016-3783-2. Epub 2016 Apr 15. Breast Cancer Res Treat. 2016. PMID: 27083179 Free PMC article.
Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands.
Walstra CJEF, Schipper RJ, van Riet YE, van der Toorn PG, Smidt ML, Sangen MJCV, Voogd AC, Nieuwenhuijzen GAP. Walstra CJEF, et al. Breast Cancer Res Treat. 2021 Jun;187(2):499-514. doi: 10.1007/s10549-021-06154-2. Epub 2021 Mar 13. Breast Cancer Res Treat. 2021. PMID: 33713244 Free PMC article.
Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.
de Bruijn A, Schipper RJ, Voogd AC, Pullens MJJ, Bloemen JG, de Munck L, van Riet YE, Siesling S, Vriens BEP, Nieuwenhuijzen GAP. de Bruijn A, et al. Among authors: van riet ye. Cancers (Basel). 2024 Dec 16;16(24):4188. doi: 10.3390/cancers16244188. Cancers (Basel). 2024. PMID: 39766087 Free PMC article.
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trial.
Fontein DB, Charehbili A, Nortier JW, Meershoek-Klein Kranenbarg E, Kroep JR, Putter H, van Riet Y, Nieuwenhuijzen GA, de Valk B, Terwogt JM, Algie GD, Liefers GJ, Linn S, van de Velde CJ. Fontein DB, et al. Among authors: van riet y, van de velde cj. Eur J Cancer. 2014 Sep;50(13):2190-200. doi: 10.1016/j.ejca.2014.05.010. Epub 2014 Jun 23. Eur J Cancer. 2014. PMID: 24970786 Clinical Trial.
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial.
Vliek SB, Noordhoek I, Meershoek-Klein Kranenbarg E, van Rossum AGJ, Dezentje VO, Jager A, Hokken JWE, Putter H, van der Velden AWG, Hendriks MP, Bakker SD, van Riet YEA, Tjan-Heijnen VCG, Portielje JEA, Kroep JR, Nortier JWR, van de Velde CJH, Linn SC. Vliek SB, et al. Among authors: van riet yea. J Clin Oncol. 2022 Sep 1;40(25):2934-2945. doi: 10.1200/JCO.21.00311. Epub 2022 Apr 20. J Clin Oncol. 2022. PMID: 35442755 Clinical Trial.
37 results